{"Travoprost":{"RelatedTo":"Prostaglandin F2-alpha receptor","SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB00287","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB00287","Definition":"Travoprost ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a synthetic prostaglandin F2alpha analogue. (Wikipedia) Pharmacology: Travoprost, an isopropyl ester prodrug, is a synthetic prostaglandin F2 analogue. Travoprost reduces pressure in the eye by increasing the amount of fluid that drains from the eye. Mechanism of action: Travoprost free acid is a selective FP prostanoid receptor agonist which is believed to reduce intraocular pressure by increasing uveoscleral outflow. The exact mechanism of action is unknown at this time. Drug type: Approved. Small Molecule. Drug category: Antiglaucoma preparations and miotics. Antihypertensive Agents. Ophthalmologicals. Prostaglandin analogues"}}